Browse by author
Lookup NU author(s): Professor Christopher WardORCiD
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Copyright ©The authors 2021.Our starting point is that relatively new findings into the pathogenesis and pathophysiology of airway disease in smokers that lead to chronic obstructive pulmonary disease (COPD) need to be reassessed as a whole and integrated into "mainstream" thinking along with traditional concepts which have stood the test of time. Such a refining of the accepted disease paradigm is urgently needed as thinking on therapeutic targets is currently under active reconsideration. We feel that generalised airway wall "inflammation" is unduly over-emphasised, and highlight the patchy and variable nature of the pathology (with the core being airway remodelling). In addition, we present evidence for airway wall disease in smokers/COPD as including a hypocellular, hypovascular, destructive, fibrotic pathology, with a likely spectrum of epithelial-mesenchymal transition states as significant drivers of this remodelling. Furthermore, we present data from a number of research modalities and integrate this with the aetiology of lung cancer, the role of chronic airway luminal colonisation/infection by a specific group of "respiratory" bacteria in smokers (which results in luminal inflammation) and the central role for oxidative stress on the epithelium. We suggest translation of these insights into more focus on asymptomatic smokers and early COPD, with the potential for fresh preventive and therapeutic approaches.
Author(s): Walters EH, Shukla SD, Mahmood MQ, Ward C
Publication type: Review
Publication status: Published
Journal: European Respiratory Review: an official journal of the European Respiratory Society
Online publication date: 25/05/2021
Acceptance date: 18/02/2021
ISSN (print): 0905-9180
ISSN (electronic): 1600-0617
Publisher: NLM (Medline)
PubMed id: 34039673